SPY331.89+1.83 0.55%
DIA270.89+2.48 0.92%
IXIC10,984.22+43.05 0.39%

G1 Therapeutics Q3 EPS $(0.86) Down From $(0.59) YoY

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.86) per share. This is a 45.76 percent decrease over losses of $(0.59) per share from the same period last year.

Benzinga · -

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.86) per share. This is a 45.76 percent decrease over losses of $(0.59) per share from the same period last year.